n(g),n(g')-dimethyl-l-arginine has been researched along with Ischemia in 12 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to establish a rat model of acute ischemic kidney injury by continually occluding the bilateral renal artery and renal veins, as well as to examine the role of asymmetric dimethylarginine (ADMA) in acute lung injury (ALI) induced by acute kidney injury (AKI)." | 7.81 | Role of asymmetric dimethylarginine in rat acute lung injury induced by acute ischemic kidney injury. ( Liu, X; Liu, Z; Ma, T, 2015) |
| "Asymmetric dimethylarginine (ADMA) plays role in the pathogenesis of coronary artery disease and related mortality and morbidity through a number of mechanisms." | 7.81 | Asymmetric dimethylarginine is not a good predictor of ischemia using myocardial perfusion scintigraphy. ( Aşik, M; Aslantaş, Y; Bulur, S; Doğan, AS; Erkan, ME; Ilçe, HT; Memişoğullari, R; Uçgun, T; Yildirim, M; Yildiz, N; Yilmaz, A, 2015) |
| "Primary dysmenorrhea is a common disorder among young women, and uterine ischemia plays an important role in pelvic pain." | 5.36 | Increased serum asymmetric dimethylarginine levels in primary dysmenorrhea. ( Akdemir, N; Akdemir, R; Akin, O; Bilir, C; Cinemre, H, 2010) |
| " In recent years, the emerging new understanding of the NO pathway has shown that an endogenously produced inhibitor of NOS, asymmetric dimethylarginine (ADMA), a host response to infection, may play an important role in the pathophysiology of sepsis as well as organ damage during ischemia-reperfusion." | 5.22 | A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach. ( Kellum, JA; Lee, Y; Singh, J, 2022) |
| "The aim of the present study was to establish a rat model of acute ischemic kidney injury by continually occluding the bilateral renal artery and renal veins, as well as to examine the role of asymmetric dimethylarginine (ADMA) in acute lung injury (ALI) induced by acute kidney injury (AKI)." | 3.81 | Role of asymmetric dimethylarginine in rat acute lung injury induced by acute ischemic kidney injury. ( Liu, X; Liu, Z; Ma, T, 2015) |
| "Asymmetric dimethylarginine (ADMA) plays role in the pathogenesis of coronary artery disease and related mortality and morbidity through a number of mechanisms." | 3.81 | Asymmetric dimethylarginine is not a good predictor of ischemia using myocardial perfusion scintigraphy. ( Aşik, M; Aslantaş, Y; Bulur, S; Doğan, AS; Erkan, ME; Ilçe, HT; Memişoğullari, R; Uçgun, T; Yildirim, M; Yildiz, N; Yilmaz, A, 2015) |
| " We examined the hypothesis that HC may inhibit ischemia-induced angiogenesis by inhibition of EDNO in a rat model of unilateral hindlimb ischemia and that oral L-arginine supplementation, a substrate for NO synthase, may prevent HC-related impairment of angiogenesis." | 3.70 | Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. ( Duan, J; Ikeda, H; Imaizumi, T; Katoh, A; Kawata, H; Murohara, T; Sasaki, K; Shintani, S; Yamamoto, N, 2000) |
| "Primary dysmenorrhea is a common disorder among young women, and uterine ischemia plays an important role in pelvic pain." | 1.36 | Increased serum asymmetric dimethylarginine levels in primary dysmenorrhea. ( Akdemir, N; Akdemir, R; Akin, O; Bilir, C; Cinemre, H, 2010) |
| "Hindlimb ischemia was surgically induced in C57BL/6J mice, apo E-deficient mice, or transgenic mice overexpressing dimethylarginine dimethylaminohydrolase (DDAH)." | 1.33 | ADMA regulates angiogenesis: genetic and metabolic evidence. ( Achan, V; Cooke, JP; Heeschen, C; Ho, HK; Jang, JJ; Kimoto, M; Stuehlinger, M; Vallance, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, J | 1 |
| Lee, Y | 1 |
| Kellum, JA | 1 |
| Madaric, J | 1 |
| Valachovicova, M | 1 |
| Paulis, L | 1 |
| Pribojova, J | 1 |
| Mateova, R | 1 |
| Sebekova, K | 1 |
| Postulkova, L | 1 |
| Madaricova, T | 1 |
| Bucova, M | 1 |
| Mistrik, M | 1 |
| Vulev, I | 1 |
| Ma, T | 1 |
| Liu, X | 1 |
| Liu, Z | 1 |
| Erkan, ME | 1 |
| Aşik, M | 1 |
| Uçgun, T | 1 |
| Yildiz, N | 1 |
| Yilmaz, A | 1 |
| Aslantaş, Y | 1 |
| Bulur, S | 1 |
| Ilçe, HT | 1 |
| Yildirim, M | 1 |
| Memişoğullari, R | 1 |
| Doğan, AS | 1 |
| Kocak, C | 1 |
| Kocak, FE | 1 |
| Akcilar, R | 1 |
| Bayat, Z | 1 |
| Aras, B | 1 |
| Metineren, MH | 1 |
| Yucel, M | 1 |
| Simsek, H | 1 |
| Shibata, R | 1 |
| Ueda, S | 1 |
| Yamagishi, S | 1 |
| Kaida, Y | 1 |
| Matsumoto, Y | 1 |
| Fukami, K | 1 |
| Hayashida, A | 1 |
| Matsuoka, H | 1 |
| Kato, S | 1 |
| Kimoto, M | 3 |
| Okuda, S | 1 |
| Leypoldt, F | 1 |
| Choe, CU | 1 |
| Gelderblom, M | 1 |
| von Leitner, EC | 1 |
| Atzler, D | 1 |
| Schwedhelm, E | 1 |
| Gerloff, C | 1 |
| Sydow, K | 2 |
| Böger, RH | 1 |
| Magnus, T | 1 |
| Akdemir, N | 1 |
| Cinemre, H | 1 |
| Bilir, C | 1 |
| Akin, O | 1 |
| Akdemir, R | 1 |
| Jacobi, J | 1 |
| von Degenfeld, G | 1 |
| Zhang, Y | 1 |
| Dayoub, H | 1 |
| Wang, B | 1 |
| Patterson, AJ | 1 |
| Blau, HM | 1 |
| Cooke, JP | 2 |
| Achan, V | 1 |
| Ho, HK | 1 |
| Heeschen, C | 1 |
| Stuehlinger, M | 1 |
| Jang, JJ | 1 |
| Vallance, P | 1 |
| Duan, J | 1 |
| Murohara, T | 1 |
| Ikeda, H | 1 |
| Katoh, A | 1 |
| Shintani, S | 1 |
| Sasaki, K | 1 |
| Kawata, H | 1 |
| Yamamoto, N | 1 |
| Imaizumi, T | 1 |
| Masuda, H | 1 |
| Tsujii, T | 1 |
| Okuno, T | 1 |
| Kihara, K | 1 |
| Goto, M | 1 |
| Azuma, H | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Ischemia
| Article | Year |
|---|---|
A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach.
Topics: Animals; Arginine; Humans; Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Sepsis | 2022 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Ischemia
| Article | Year |
|---|---|
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia.
Topics: Aged; Arginine; Autografts; Extremities; Female; Follow-Up Studies; Humans; Ischemia; Leukocytes, Mo | 2017 |
10 other studies available for n(g),n(g')-dimethyl-l-arginine and Ischemia
| Article | Year |
|---|---|
Role of asymmetric dimethylarginine in rat acute lung injury induced by acute ischemic kidney injury.
Topics: Actins; Acute Kidney Injury; Acute Lung Injury; Animals; Arginine; Enzyme Activation; HSP27 Heat-Sho | 2015 |
Asymmetric dimethylarginine is not a good predictor of ischemia using myocardial perfusion scintigraphy.
Topics: Arginine; Coronary Artery Disease; Echocardiography; Female; Humans; Ischemia; Male; Middle Aged; My | 2015 |
Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Antioxidants; Apoptosis; Arginine; Benzimidazole | 2016 |
Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
Topics: Adenoviridae; Amidohydrolases; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Ge | 2009 |
Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
Topics: Amidohydrolases; Animals; Arginine; Brain; Endothelium, Vascular; Genotype; Infarction, Middle Cereb | 2009 |
Increased serum asymmetric dimethylarginine levels in primary dysmenorrhea.
Topics: Adolescent; Adult; Arginine; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Coho | 2010 |
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
Topics: Amidohydrolases; Animals; Arginine; Enzyme Induction; Female; Hindlimb; Humans; Ischemia; Laser-Dopp | 2005 |
ADMA regulates angiogenesis: genetic and metabolic evidence.
Topics: Animals; Arginine; Blotting, Western; Disease Models, Animal; Female; Hypercholesterolemia; Ischemia | 2005 |
Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism.
Topics: Administration, Oral; Animals; Arginine; Body Weight; Cholesterol, Dietary; Collateral Circulation; | 2000 |
Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.
Topics: Animals; Arginine; Calcium; Carbachol; Cholinergic Agonists; Cyclic GMP; Disease Models, Animal; Dos | 2002 |